1.4 USD
-0.21 (-13.04%)
1.37 USD
-0.03 (-2.14%)
Taking everything into account, NCI scores 4 out of 10 in our fundamental rating. NCI was compared to 45 industry peers in the Textiles, Apparel & Luxury Goods industry. NCI has an excellent financial health rating, but there are some minor concerns on its profitability. NCI is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year NCI was profitable.
1.2 Ratios
With an excellent Return On Assets value of 7.33%, NCI belongs to the best of the industry, outperforming 82.22% of the companies in the same industry.
Looking at the Return On Equity, with a value of 17.36%, NCI is in the better half of the industry, outperforming 75.56% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 11.38%, NCI is in the better half of the industry, outperforming 75.56% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.33% | ||
| ROE | 17.36% | ||
| ROIC | 11.38% |
ROA(3y)13.48%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
NCI has a Profit Margin of 3.41%. This is comparable to the rest of the industry: NCI outperforms 57.78% of its industry peers.
In the last couple of years the Profit Margin of NCI has grown nicely.
NCI has a Operating Margin (4.67%) which is comparable to the rest of the industry.
NCI's Operating Margin has improved in the last couple of years.
NCI has a Gross Margin of 25.43%. This is amonst the worse of the industry: NCI underperforms 80.00% of its industry peers.
NCI's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.67% | ||
| PM (TTM) | 3.41% | ||
| GM | 25.43% |
OM growth 3Y38.21%
OM growth 5YN/A
PM growth 3Y14.72%
PM growth 5YN/A
GM growth 3Y30.72%
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), NCI is creating some value.
Compared to 1 year ago, NCI has about the same amount of shares outstanding.
Compared to 1 year ago, NCI has an improved debt to assets ratio.
2.2 Solvency
NCI has an Altman-Z score of 2.65. This is not the best score and indicates that NCI is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of NCI (2.65) is comparable to the rest of the industry.
NCI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.65 |
ROIC/WACC1.08
WACC10.49%
2.3 Liquidity
NCI has a Current Ratio of 1.85. This is a normal value and indicates that NCI is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.85, NCI is in line with its industry, outperforming 42.22% of the companies in the same industry.
A Quick Ratio of 1.70 indicates that NCI should not have too much problems paying its short term obligations.
NCI's Quick ratio of 1.70 is amongst the best of the industry. NCI outperforms 84.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.85 | ||
| Quick Ratio | 1.7 |
3. Growth
3.1 Past
NCI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 75.16%, which is quite impressive.
Measured over the past years, NCI shows a quite strong growth in Earnings Per Share. The EPS has been growing by 15.35% on average per year.
The Revenue has grown by 16.75% in the past year. This is quite good.
The Revenue has been decreasing by -0.68% on average over the past years.
EPS 1Y (TTM)75.16%
EPS 3Y15.35%
EPS 5YN/A
EPS Q2Q%34.02%
Revenue 1Y (TTM)16.75%
Revenue growth 3Y-0.68%
Revenue growth 5YN/A
Sales Q2Q%-24%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 4.24, the valuation of NCI can be described as very cheap.
Based on the Price/Earnings ratio, NCI is valued cheaper than 97.78% of the companies in the same industry.
NCI's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.22.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 4.24 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NCI indicates a rather cheap valuation: NCI is cheaper than 97.78% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 4.51 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
NCI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
1.4
-0.21 (-13.04%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)
Earnings (Next)
Inst Owners0.08%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner Change0%
Market Cap5.68M
Revenue(TTM)295.90M
Net Income(TTM)10.10M
Analysts60
Price TargetN/A
Short Float %2.8%
Short Ratio0.01
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 4.24 | ||
| Fwd PE | N/A | ||
| P/S | 0.15 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.76 | ||
| P/tB | 0.96 | ||
| EV/EBITDA | 4.51 |
EPS(TTM)0.33
EY23.57%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS9.37
BVpS1.84
TBVpS1.45
PEG (NY)N/A
PEG (5Y)N/A
Graham Number3.7
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.33% | ||
| ROE | 17.36% | ||
| ROCE | 13.79% | ||
| ROIC | 11.38% | ||
| ROICexc | 11.59% | ||
| ROICexgc | 13.25% | ||
| OM | 4.67% | ||
| PM (TTM) | 3.41% | ||
| GM | 25.43% | ||
| FCFM | N/A |
ROA(3y)13.48%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.04%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y38.21%
OM growth 5YN/A
PM growth 3Y14.72%
PM growth 5YN/A
GM growth 3Y30.72%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover2.15
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.85 | ||
| Quick Ratio | 1.7 | ||
| Altman-Z | 2.65 |
F-ScoreN/A
WACC10.49%
ROIC/WACC1.08
Cap/Depr(3y)604.44%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.96%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)75.16%
EPS 3Y15.35%
EPS 5YN/A
EPS Q2Q%34.02%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)16.75%
Revenue growth 3Y-0.68%
Revenue growth 5YN/A
Sales Q2Q%-24%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y45.08%
EBIT growth 3Y37.27%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y62.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y100.87%
OCF growth 3Y-65.32%
OCF growth 5YN/A
NEO-CONCEPT INTL GROUP HLD-A / NCI FAQ
What is the fundamental rating for NCI stock?
ChartMill assigns a fundamental rating of 4 / 10 to NCI.
Can you provide the valuation status for NEO-CONCEPT INTL GROUP HLD-A?
ChartMill assigns a valuation rating of 3 / 10 to NEO-CONCEPT INTL GROUP HLD-A (NCI). This can be considered as Overvalued.
Can you provide the profitability details for NEO-CONCEPT INTL GROUP HLD-A?
NEO-CONCEPT INTL GROUP HLD-A (NCI) has a profitability rating of 4 / 10.
Can you provide the PE and PB ratios for NCI stock?
The Price/Earnings (PE) ratio for NEO-CONCEPT INTL GROUP HLD-A (NCI) is 4.24 and the Price/Book (PB) ratio is 0.76.
Can you provide the financial health for NCI stock?
The financial health rating of NEO-CONCEPT INTL GROUP HLD-A (NCI) is 7 / 10.